Charco Neurotech

Call Directions Website

Charco Neurotech Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Charco Neurotech, Community Center, wellington house, Cambridge.

For Emma, the impact of CUE1+ has been felt in some very everyday moments.Feeling more comfortable sitting in the car. D...
19/10/2026

For Emma, the impact of CUE1+ has been felt in some very everyday moments.

Feeling more comfortable sitting in the car. Driving more. Being able to write more easily.

“Even though my arm’s still shaking, the tremor goes away when I write.”

Thank you, Emma, for sharing your experience with us.

The CUE1+ has been through multiple stages of testing, from early user testing, to pilot research, to more rigorous clin...
15/10/2026

The CUE1+ has been through multiple stages of testing, from early user testing, to pilot research, to more rigorous clinical investigation.

Each stage asks different questions.

Early testing:
Does the concept appear useful? What happens when people actually use it?

Pilot research:
Can we measure changes in movement and other outcomes?

Randomised controlled research:
What happens when we compare the active device with a sham device under controlled conditions?

In a randomised, double-blind, sham-controlled trial we tested 50 people with Parkinson’s across two NHS sites and found greater improvements in motor symptoms in the active CUE1+ group compared with the sham group.

That doesn’t mean the research journey is over, quite the opposite. Every study adds another piece to the picture helping researchers understand the potential benefits, limitations and the people who may benefit most.

That’s how evidence grows.

Question. Test. Measure. Learn. Repeat.

Head to the website to read the full study and discover more about the research behind the CUE1+.

https://charconeurotech.com/evidence/

It might seem surprising that a small vibration on the chest could influence the way someone with Parkinson’s moves.But ...
12/10/2026

It might seem surprising that a small vibration on the chest could influence the way someone with Parkinson’s moves.

But the idea behind the CUE1+ comes from a much broader area of research into sensory cueing.

Our brains constantly use information from our senses to help coordinate movement.

Rhythmic sensory cues can provide an external signal that may help with things like:

- Movement initiation
- Walking rhythm
- Movement coordination
- Freezing of gait

The CUE1+ combines vibrotactile stimulation with rhythmic cueing, delivering gentle stimulation through a wearable device.

The aim isn’t to “fix” Parkinson’s.

Instead, we provide an additional sensory cue that can help support movement alongside a person’s existing treatment plan.

Have you heard of vibrotactile stimulation as a treatment for Parkinson’s before or did this surprise you?

It might seem surprising that a small vibration on the chest could influence the way someone with Parkinson’s moves.But ...
12/10/2026

It might seem surprising that a small vibration on the chest could influence the way someone with Parkinson’s moves.

But the idea behind the CUE1+ comes from a much broader area of research into sensory cueing.

Our brains constantly use information from our senses to help coordinate movement.

Rhythmic sensory cues can provide an external signal that may help with things like:

- Movement initiation
- Walking rhythm
- Movement coordination
- Freezing of gait

The CUE1+ combines vibrotactile stimulation with rhythmic cueing, delivering gentle stimulation through a wearable device.

The aim isn't to “fix” Parkinson’s.

Instead, we provide an additional sensory cue that can help support movement alongside a person's existing treatment plan.

Have you heard of vibrotactile stimulation as a treatment for Parkinson's before or did this surprise you?

REGISTER YOUR INTEREST TODAY!If you’ve been waiting for the opportunity to purchase the CUE1+, you can now register your...
07/10/2026

REGISTER YOUR INTEREST TODAY!

If you’ve been waiting for the opportunity to purchase the CUE1+, you can now register your interest and make sure you’re among the first to hear when it becomes available.

Visit the link in our bio to register your interest and stay up to date with the latest developments from Charco Neurotech.

Any questions, drop us a message we are always happy to chat.

When it comes to Parkinson’s, promising ideas need to be tested properly. That’s why clinical research matters.The CUE1+...
05/10/2026

When it comes to Parkinson’s, promising ideas need to be tested properly. That’s why clinical research matters.

The CUE1+ uses vibrotactile stimulation and rhythmic cueing techniques that have been studied for their potential to support movement, gait and movement initiation in Parkinson’s.

And the evidence base is continuing to grow.

We recently conducted a double-blind, sham-controlled randomised trial involving 50 people with Parkinson’s, conducted across two NHS sites, the trial found that people using the active CUE1+ showed a greater improvement in motor symptoms than those using a sham device over 12 weeks.

The study also found improvements in quality of life.

Importantly, this research was designed to assess safety, usability and tolerability first, with clinical outcomes explored alongside these measures.

For us, evidence isn’t about making big promises.

It’s about asking the right questions, testing ideas rigorously, and continuing to learn.

Our Brand New Website is LIVE!We’re incredibly proud to launch the new Charco Neurotech website.It’s been designed to gi...
29/09/2026

Our Brand New Website is LIVE!

We’re incredibly proud to launch the new Charco Neurotech website.

It’s been designed to give you a clearer look at who we are, what we do, and most importantly, how we’re working to support people living with Parkinson’s.

You can explore more about our approach, how CUE1+ works, the people behind Charco, and the science and evidence that underpin our technology. For us, being evidence led and scientifically grounded isn’t just important, it’s fundamental to what we do.

Whether you’re living with Parkinson’s, supporting someone who is, a healthcare professional, researcher, or simply want to learn more about what we’re working towards, we’d love you to take a look.

👉 Explore the new website: charconeurotech.com / via the link in our bio.

We hope you enjoy exploring it as much as we’ve enjoyed bringing it to life.

Parkinsons ParkinsonsDisease Neurotech HealthTech MedTech ParkinsonsResearch ScienceAndInnovation

Individual experiences matter. They help us understand what living with Parkinson’s can be like and how CUE1+ may fit in...
24/09/2026

Individual experiences matter. They help us understand what living with Parkinson’s can be like and how CUE1+ may fit into everyday life.

But independent research helps us build a bigger picture.

Across 3 independent studies, involving 76 CUE1+ users, an average 12-point improvement in MDS-UPDRS Part III scores was observed.

MDS-UPDRS Part III is a recognised clinical assessment used to measure the motor symptoms of Parkinson’s giving researchers a structured way to measure changes in movement.

And this evidence has been “peer-reviewed” meaning the data has been further critiqued and validated by independent subject matter experts.

Because when it comes to developing and evaluating technology for Parkinson’s, the more robust the evidence, the more we can understand.

Move freely. Live Fully With Charco.
21/09/2026

Move freely. Live Fully With Charco.

MYTH vs EVIDENCE: Parkinson’s symptom management 🧠MYTH: There’s nothing you can do about Parkinson’s symptoms.EVIDENCE: ...
17/09/2026

MYTH vs EVIDENCE: Parkinson’s symptom management 🧠

MYTH: There’s nothing you can do about Parkinson’s symptoms.
EVIDENCE: While there’s currently no cure for Parkinson’s, symptoms can be managed in a number of ways, including medication, physiotherapy, occupational therapy, exercise and other supportive treatments.

MYTH: Parkinson’s is just about tremor.
EVIDENCE: Parkinson’s can affect movement in many different ways, including stiffness, slowness, balance and gait as well as a wide range of non-motor symptoms.

MYTH: Medication is the only way to manage symptoms.
EVIDENCE: Medication is an important part of treatment, but it can sit alongside other solutions.

MYTH: If something is a Parkinson’s symptom, it must be Parkinson’s itself.
EVIDENCE: Some changes can be related to medication side effects, too. That’s why tracking symptoms and discussing changes with your Parkinson’s team is so important.

Parkinson’s is complex and symptom management shouldn’t be one-size-fits-all.

Understanding what’s happening, tracking changes and working with your healthcare team can help you find the right combination of support for you.

Address

Wellington House
Cambridge
CB11BH

Telephone

+442081640844

Website

Alerts

Be the first to know and let us send you an email when Charco Neurotech posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category